Nuclear Medicine Market Research Report Information By Product Type ( Diagnostic Nuclear Medicine (SPECT Radiopharmaceuticals [ Tc-99m, TI-201, Ga-67, I-123, and Others], Pet Radiopharmaceuticals [Tc-99m, TI-201, Ga-67, I-123, and Others]), Therapeutic Nuclear Medicine (Alpha Emitters[ Ra-223], Beta Emitters[I-131, Y-90, Sm-153, Lu-177, Re-186, and Others]), Brachytherapy Isoptopes [Ir-192, I-125, Pd-103, Cs-131, and Others]), By Application (Diagnostic Applications SPECT Applications[Cardiology, Neurology, Lymphoma, Thyroid, and Others]
According to MRFR analysis, the global Nuclear Medicine Market is expected to register a CAGR of 13.2% from 2022 to 2030 and hold a value of over USD 18.76 billion by 2030.
The field of nuclear medicine has undergone significant growth and innovation in recent years, transforming the landscape of medical diagnostics and treatment. Nuclear medicine involves the use of small amounts of radioactive materials, known as radiopharmaceuticals, to diagnose and treat a variety of medical conditions. This dynamic and rapidly evolving sector is a critical component of modern healthcare, providing valuable insights into disease detection, monitoring, and therapy.
Get Free Sample PDF Brochure @ https://www.marketresearchfuture.com/sample_request/6674
Segmentation
Diagnostic nuclear medicine and therapeutic nuclear medicine are both included in the market segmentation for nuclear medicine based on product type.
Applications such as diagnostic and therapeutic ones make up the market segmentation for nuclear medicine. Over the forecast period, 2022–2030, the diagnostic applications segment is anticipated to dominate the market. This is because SPECT and PET applications are expanding, healthcare awareness is rising, and more money is being invested in the research and development of innovative nuclear medications for the treatment of cancer.
The market data for nuclear medicine has been divided into hospitals and diagnostic facilities, research institutes, and other entities. The category of hospitals and diagnostic facilities, which dominated the market in 2021, is anticipated to develop at a quicker rate over the forecast period of 2022 to 2030. The increased number of nuclear imaging treatments and improved efficiency in handling these sensitive things at hospitals and clinics are credited with the growing rate.
Key Players
Some of the top market players are
Regional Analysis
The market for nuclear medicine throughout the globe may be broken down into four distinct regions: North America, Europe, Asia Pacific, and the rest of the world. Nuclear medicine is the most popular treatment option in the United States.
Browse In-depth Market Research Report (100 Pages) on Nuclear Medicine: https://www.marketresearchfuture.com/reports/nuclear-medicine-market-6674
The United States of America is the biggest client market for radioisotopes within North America, while Canada is the greatest producer of Tc-99m. Both of these countries are located on the continent. Although the U.S. was the region’s top revenue producer, the country’s supremacy is projected to wane as more people turn to nuclear medicine for various therapeutic purposes and as system volumes increase.
Discover More Research Reports on Healthcare Industry by Market Research Future:
Telemedicine Market Research Report Information By Component (Product {Software and Hardware} and Services {Tele-Consulting, Tele-Monitoring, Tele-Education, and Others}), By Type (Tele-Nursing, Tele-Pharmacy, Tele-Radiology, Tele-Dermatology, Tele-Oncology and Others), By Deployment (On-Premise and Cloud-Based), By End User (Hospitals and Clinics, Home Care and Others), By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Forecast Till 2032
Telehealth Market Research Report Information By Component (Hardware, Software, and Services), By Mode of Delivery (Web/Cloud-Based, and On-Premise), By Application (Radiology, Cardiology, Primary Care, Neurophysiology, and others), By End Users (Hospitals and Clinics, Diagnostic Centers, Home Care, and others), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2030
Veterinary Medicine Market Research Report Information By Animal Type (Domesticated and Companion), Product (Drugs and Vaccines), Route of Administration (Oral, Parental), Distribution Channel (Veterinary Hospitals & Clinics, Retail Stores, Online Pharmacies), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2032
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.